{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:57:24Z","timestamp":1761541044109},"reference-count":37,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2011,3,21]],"date-time":"2011-03-21T00:00:00Z","timestamp":1300665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2011,5]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Vitamin K antagonists (VKA) are effective in primary and secondary prevention of thromboembolism, but the associated risk of bleeding is an important limitation. The majority of bleeds are clinically mild. In this study, we assessed whether these minor bleeds are associated with major bleeding, when controlling for other important risk indicators, including the achieved quality of anticoagulation. For this, 5898 patients attending a specialized anticoagulation clinic were retrospectively studied for 1\u2003year after initiation of VKA therapy. The risk of major bleeding was estimated using a multivariate piecewise exponential model with time\u2010varying exposure for occurring minor bleeds. In patients with a minor bleed (<jats:italic>N<\/jats:italic>\u2003=\u20031015) subsequent major bleeding occurred more frequently than in patients without a minor bleed (<jats:italic>N<\/jats:italic>\u2003=\u20034883), with an incidence rate of 2\u00b73 [95% confidence interval (CI) 1\u00b74\u20133\u00b77] vs. 1\u00b72 per 100 person\u2010years (95% CI 0\u00b79\u20131\u00b77). The adjusted relative risk of subsequent major bleeding after a minor bleed was 2\u00b79 (95% CI 1\u00b71\u20137\u00b72, <jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7024). The percentage of time that a patient had an International Normalized Ratio (INR) above 5 was also independently associated with major bleeding, with a 2\u00b72\u2010fold increased risk in patients with at least 9% of time above INR 5 (95% CI 1\u00b73\u20134\u00b70, <jats:italic>P<\/jats:italic>\u2003=\u20030\u00b7006). Minor bleeds alert for subsequent major bleeding, independent of the quality of anticoagulation.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2011.08656.x","type":"journal-article","created":{"date-parts":[[2011,3,21]],"date-time":"2011-03-21T14:45:46Z","timestamp":1300718746000},"page":"508-514","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Minor bleeds alert for subsequent major bleeding in patients using vitamin K antagonists"],"prefix":"10.1111","volume":"153","author":[{"given":"Nic J. G. M.","family":"Veeger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margriet","family":"Piersma\u2010Wichers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans L.","family":"Hillege","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,3,21]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.293.6.690"},{"key":"e_1_2_8_3_1","first-page":"1","volume-title":"Survival Analysis Using the SAS\u00ae System: A Practical Guide","author":"Allison P.D.","year":"1995"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0670"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0735-1097(96)00020-4"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(98)00198-3"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0905561"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2004.11.015"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)09409-6"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH02-10-0179"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-007-0104-y"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.290.20.2685"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.11.4237"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.653048"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.19.2176"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.5.457"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-11-200312020-00007"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.161.20.2458"},{"key":"e_1_2_8_19_1","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/archinte.1993.00410130073007","article-title":"Bleeding complications in oral anticoagulant therapy. An analysis of risk factors","volume":"153","author":"van der Meer F.J.","year":"1993","journal-title":"Archives of Internal Medicine"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.d01-3544.x"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14841-6"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH08-11-0730"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)01109-9"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2005.05417.x"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0037-1616088"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.126.6.1938"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1651587"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1023276710895"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2005.01204.x"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.08-0674"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.130.5.1390"},{"key":"e_1_2_8_32_1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/archinte.1996.00440040081009","article-title":"Bleeding during antithrombotic therapy in patients with atrial fibrillation","volume":"156","author":"The Stroke Prevention in Atrial Fibrillation Investigators","year":"1996","journal-title":"Archives of Internal Medicine"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05348.x"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01997.x"},{"key":"e_1_2_8_35_1","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/archinte.1996.00440100095011","article-title":"Management and prognosis of life\u2010threatening bleeding during warfarin therapy. National Consortium of Anticoagulation Clinics","volume":"156","author":"White R.H.","year":"1996","journal-title":"Archives of Internal Medicine"},{"key":"e_1_2_8_36_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra032424"},{"key":"e_1_2_8_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.165.6.703-a"},{"key":"e_1_2_8_38_1","doi-asserted-by":"publisher","DOI":"10.1592\/phco.24.14.1311.43144"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2011.08656.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2011.08656.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/j.1365-2141.2011.08656.x","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2011.08656.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T03:25:39Z","timestamp":1694402739000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2011.08656.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,21]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["10.1111\/j.1365-2141.2011.08656.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2011.08656.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,21]]},"assertion":[{"value":"2011-03-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}